A California supplement maker is drawing scrutiny from the FDA for violating GMP regulations and misbranding products as drugs. Source: Drug Industry Daily

The House Oversight Committee threatened to subpoena Mylan for full documents related to price increases for its EpiPen. Source: Drug Industry Daily

Two lawmakers behind the Cures Act have asked the Office of Management and Budget to clarify whether the federal hiring freeze applies to the FDA, raising concerns that the freeze…

A complaint from the Federal Trade Commission alleges Shire ViroPharma unlawfully stifled competition for its branded drugs. Source: Drug Industry Daily

Two congressmen introduced right-to-try legislation in the House this week, which could find broad support from Congress and the White House. Source: Drug Industry Daily

More than 160 biotech executives, investors and researchers have signed on to a letter opposing President Trump’s executive order restricting immigration from seven Middle Eastern and African countries. Source: Drug…